Empirical Health Achieves Major Milestone with 100,000 Patients in a Transformative Year
Empirical Health has officially surpassed the milestone of 100,000 patients, signaling a groundbreaking year of growth and innovation in preventive medicine. The company, renowned for its use of advanced biomarkers and AI-driven insights, has experienced exceptional momentum in product development, clinical outreach, and scientific contributions throughout 2025.
In May 2025, Empirical Health launched an advanced heart health program that includes one of the most comprehensive biomarker assessments available in consumer preventive care. This program evaluates 100 advanced cardiovascular and metabolic biomarkers, offering personalized care plans crafted by experienced clinicians, all powered by the company’s proprietary health models. Since its introduction, this program has rapidly gained popularity, enabling patients to identify health risks earlier and take proactive measures to enhance their long-term health outcomes.
The soaring adoption of this innovative program has contributed significantly to the company’s growth, resulting in a staggering 30-fold revenue increase year-over-year. Monthly revenue growth averaged 41% over the last six months, indicating a strong demand for Empirical’s forward-thinking approach to preventive care. The company has also vastly expanded its clinical footprint, growing its operations from just four U.S. states in 2023 to 30 by the end of 2025.
Recognizing its commitment to design excellence, Empirical Health was celebrated by Apple in September 2025 for its app, hailed for its “gorgeous new design” and seamless integration of complex health insights into users’ daily wellness routines.
Additionally, in December 2025, Empirical Health further cemented its role as a leader in scientific innovation when its research on health foundation models was accepted at NeurIPS, a prestigious conference in artificial intelligence. This achievement emphasizes Empirical’s dedication to enhancing AI-powered healthcare solutions and developing more accurate, individualized health predictions.
Brandon Ballinger, CEO of Empirical Health, stated, “Reaching 100,000 patients is an exhilarating milestone — but it’s just the start. Our goal is to make high-resolution, proactive healthcare accessible to all. The growth we are witnessing shows a clear desire for deep health insights and actionable tools.”
Looking ahead to 2026, Empirical Health aims to broaden its biomarker panels, strengthen integrations with consumer health platforms, and continue its investment in clinical research to validate and scale its preventive care models.
Empirical Health is at the forefront of next-generation preventive care, utilizing advanced biomarkers and health foundation models to provide tailored health insights and actionable care plans. With a combination of scientific rigor and exceptional design, the company empowers individuals to understand their health at a molecular level, aiming for measurable improvements in long-term wellness.
